Analyst Ratings for Par Pharmaceutical (PRX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/9/2011 | Barclays | N/A | New Coverage | Equalweight (N/A) |
35.00 (N/A) |
31.46 (32.89) |
4.55% | Details |
| 10/6/2011 | ThinkEquity | N/A | New Coverage | Buy (N/A) |
35.00 (N/A) |
27.87 (32.89) |
18.01% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
